Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
L
Lavipharm SA
F:BXA0
Lavipharm SA
F:BXA0
Price:
1.47
EUR
0.55%
Market Closed
Market Cap:
€275.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
L
|
Lavipharm SA
F:BXA0
|
GR |
|
Bank of the Philippine Islands
OTC:BPHLF
|
PH |
|
S
|
secunet Security Networks AG
XMUN:YSN
|
DE |
|
I
|
IDeA Indonesia Akademi Tbk PT
IDX:IDEA
|
ID |
|
Sky Gold Corp
F:QSG
|
CA |
|
Notorious Pictures SpA
F:2FK
|
IT |
|
M
|
Mathios Refractory SA
ATHEX:MATHIO
|
GR |
|
K
|
Kyowa Kirin Co Ltd
SWB:KY4
|
JP |
|
A
|
Adhi Kartiko Pratama Tbk PT
IDX:NICE
|
ID |
|
I
|
Italmobiliare SpA
F:ITM1
|
IT |
|
P
|
Pollux Properties Indonesia Tbk PT
IDX:POLL
|
ID |
|
A
|
Agriauto Industries Ltd
KAR:AGIL
|
PK |
|
H
|
Hydrogene De France SA
PAR:HDF
|
FR |
|
E
|
Euwax AG
XMUN:EUX
|
DE |
|
E
|
Elahi Cotton Mills Ltd
KAR:ELCM
|
PK |
|
S
|
SM Culture & Contents Co Ltd
KOSDAQ:048550
|
KR |
Wall St Price Targets
BXA0 Price Forecast
Based on 3 analysts
Based on 3 analysts
-14% Downside
from
€1.47
today
Lavipharm SA (BXA0)’s 12-month stock price forecast through October 2027 has a consensus target of €1.26, implying 14% downside. The forecast is based on price targets from 3 Wall Street analysts.
Lavipharm SA Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BXA0's stock price target?
Price Target
1.26
EUR
1.26
EUR
According to Wall Street analysts, the average 1-year price target for BXA0 is 1.26 EUR with a low forecast of 1.25 EUR and a high forecast of 1.3 EUR.
What is the Revenue forecast for Lavipharm SA?
Projected CAGR
37%
37%
Over the last 13 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 3 years is 37%.
What is the Gross Profit forecast for Lavipharm SA?
Projected CAGR
38%
38%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 3%. The projected CAGR for the next 3 years is 38%.
What is the Operating Income forecast for Lavipharm SA?
Projected CAGR
62%
62%
The compound annual growth rate for Operating Income over the next 3 years is 62%.
What is the Pre-Tax Income forecast for Lavipharm SA?
Projected CAGR
71%
71%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 71%.
What is the Net Income forecast for Lavipharm SA?
Projected CAGR
70%
70%
The compound annual growth rate for Net Income over the next 3 years is 70%.